Gregory L. Shiferman - 01 Nov 2024 Form 3 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Senior Vice President, General Counsel and Secretary Exhibit Index: 24.1 Power of Attorney
Signature
Brandon Marsh, attorney in fact for Gregory Shiferman
Issuer symbol
SAGE
Transactions as of
01 Nov 2024
Net transactions value
$0
Form type
3
Filing time
01 Nov 2024, 16:23:37 UTC
Next filing
27 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SAGE Common Stock 14,967 01 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SAGE Stock Option (Right to buy) 01 Nov 2024 Common Stock 6,000 $23.02 Direct F2
holding SAGE Stock Option (Right to buy) 01 Nov 2024 Common Stock 20,608 $22.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 153 shares of Common Stock and (ii) 14,814 shares of Common Stock issuable under restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan (the "Plan") that vest periodically subject to the Reporting Person's continued service. Each RSU represents the right to receive one share of Common Stock upon vesting.
F2 This option was granted on February 13, 2024, pursuant to the Plan. The shares underlying the option vest over four years, with 25% of the shares vesting on February 13, 2025, and the remaining shares vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.
F3 This option was granted on February 21, 2024, pursuant to the Plan. The shares underlying the option vest in equal monthly installments over 18 months, with the first installment vesting on March 21, 2024, and the remaining shares vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.

Remarks:

Senior Vice President, General Counsel and Secretary Exhibit Index: 24.1 Power of Attorney